Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Riedl

Showing results (171-180 of 201) with videos related to

Pageof 21
Sort By:
Genome Medicine|February 24, 2020
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancerQing Zhou, Samantha O Perakis, Peter Ulz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2026
Overcoming adaptive resistance to KRASG12D blockade in pancreatic cancer through vertical pathway inhibitionQingxiang Lin, Alvin A Morales-Giron, Conrad Sander, et al.
The Journal of Nutrition|November 27, 2018
A Novel Tomato-Soy Juice Induces a Dose-Response Increase in Urinary and Plasma Phytochemical Biomarkers in Men with Prostate CancerElizabeth M Grainger, Nancy E Moran, David M Francis, et al.
Annals of Surgical Oncology|September 13, 2017
Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort StudyFlorian Posch, Richard Partl, Carmen Döller, et al.
ESMO Open|September 24, 2020
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancerSamantha O Perakis, Sabrina Weber, Qing Zhou, et al.
Scientific Reports|April 5, 2019
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysisFlorian Moik, Jakob M Riedl, Thomas Winder, et al.
Therapeutic Advances in Medical Oncology|March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
Allergy|April 27, 2011
Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitisS Huerta-Yepez, G J Baay-Guzman, I G Bebenek, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysisJakob M Riedl, Florian Posch, Lena Horvath, et al.
JACC. Cardiooncology|January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint InhibitorsFlorian Moik, Jakob M Riedl, Dominik Barth, et al.
Pageof 21

Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
Genome Medicine|February 24, 2020
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancerQing Zhou, Samantha O Perakis, Peter Ulz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2026
Overcoming adaptive resistance to KRASG12D blockade in pancreatic cancer through vertical pathway inhibitionQingxiang Lin, Alvin A Morales-Giron, Conrad Sander, et al.
The Journal of Nutrition|November 27, 2018
A Novel Tomato-Soy Juice Induces a Dose-Response Increase in Urinary and Plasma Phytochemical Biomarkers in Men with Prostate CancerElizabeth M Grainger, Nancy E Moran, David M Francis, et al.
Annals of Surgical Oncology|September 13, 2017
Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort StudyFlorian Posch, Richard Partl, Carmen Döller, et al.
ESMO Open|September 24, 2020
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancerSamantha O Perakis, Sabrina Weber, Qing Zhou, et al.
Scientific Reports|April 5, 2019
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysisFlorian Moik, Jakob M Riedl, Thomas Winder, et al.
Therapeutic Advances in Medical Oncology|March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
Allergy|April 27, 2011
Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitisS Huerta-Yepez, G J Baay-Guzman, I G Bebenek, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysisJakob M Riedl, Florian Posch, Lena Horvath, et al.
JACC. Cardiooncology|January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint InhibitorsFlorian Moik, Jakob M Riedl, Dominik Barth, et al.
Pageof 21